Login / Signup

Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors.

Ľudmila KřížováIva BenesovaPetra ZemanovaJan SpacekZuzana Ozaniak StrizovaZuzana HumlovaVeronika MikulováLubos PetruzelkaMichal Vocka
Published in: Journal of cancer research and clinical oncology (2024)
Our work suggests that parameters from peripheral venous blood may be potential biomarkers in NSCLC patients on ICI. The baseline values of Tregs, C3, monocytes, and MPV are especially recommended for further investigation.
Keyphrases
  • end stage renal disease
  • peripheral blood
  • ejection fraction
  • small cell lung cancer
  • chronic kidney disease
  • peritoneal dialysis
  • advanced non small cell lung cancer